EUVIMEDEUVIMED entdecken
Crossref

The Discovery of a Novel AXL/Triple Angiokinase Inhibitor Based on 6-Chloro-Substituted Indolinone and Side Chain Methyl Substitution Inhibiting Pancreatic Cancer Growth and Metastasis

Han Yao, Yuanyuan Ren, Feng Wu, Longcai Cao, Jiadai Liu, Ming Yan iD, Xingshu Li iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c02130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Han Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Receptor Protein-Tyrosine Kinases, Axl Receptor Tyrosine Kinase, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsReceptor Protein-Tyrosine KinasesAxl Receptor Tyrosine KinaseProto-Oncogene ProteinsAntineoplastic AgentsCell ProliferationHumansAnimalsMiceCell Line, TumorProtein Kinase InhibitorsStructure-Activity RelationshipIndolesMice, NudeApoptosisXenograft Model Antitumor AssaysEpithelial-Mesenchymal TransitionDrug Discovery

Substanzen

Receptor Protein-Tyrosine KinasesAxl Receptor Tyrosine KinaseProto-Oncogene ProteinsAntineoplastic AgentsProtein Kinase InhibitorsIndolesnintedanibAXL protein, human

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.

ORCID-Profile: Ming Yan, Xingshu Li

Förderung

  • National Natural Science Foundation of China
  • Guangdong Provincial Laboratory

Zitieren

APA

Yao, H., Ren, Y., Wu, F., Cao, L., Liu, J., Yan, M., & Li, X. (2025). The Discovery of a Novel AXL/Triple Angiokinase Inhibitor Based on 6-Chloro-Substituted Indolinone and Side Chain Methyl Substitution Inhibiting Pancreatic Cancer Growth and Metastasis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02130

Vancouver

Yao H, Ren Y, Wu F, Cao L, Liu J, Yan M, et al. The Discovery of a Novel AXL/Triple Angiokinase Inhibitor Based on 6-Chloro-Substituted Indolinone and Side Chain Methyl Substitution Inhibiting Pancreatic Cancer Growth and Metastasis. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02130

BibTeX
@article{Yao2025,
  author = {Yao, Han and Ren, Yuanyuan and Wu, Feng and Cao, Longcai and Liu, Jiadai and Yan, Ming and Li, Xingshu},
  title = {The Discovery of a Novel AXL/Triple Angiokinase Inhibitor Based on 6-Chloro-Substituted Indolinone and Side Chain Methyl Substitution Inhibiting Pancreatic Cancer Growth and Metastasis},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c02130}
}
Kostenlos starten →